Acinetobacter baumannii: Emergence and spread in Israeli hospitals 1997-2002

M. Paul*, M. Weinberger, Y. Siegman-Igra, T. Lazarovitch, I. Ostfeld, I. Boldur, Z. Samra, H. Shula, Y. Carmeli, B. Rubinovitch, S. Pitlik

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review


The incidence of multi-drug-resistant Acinetobacter baumannii bloodstream infections (BSIs) increased two- to four-fold in three Israeli hospitals between 1997 and 2002, accounting for 3.5-18% of all hospital-acquired BSIs. This was associated with increasing carbapenem resistance reaching 35-54%, and by a dramatic increase in carbapenem consumption. In-hospital fatality rates ranged between 47% and 58% and were significantly higher than those seen with other nosocomial Gram-negative pathogens. A. baumannii was not restricted to intensive care units, but had spread to all hospital wards. Multi-drug-resistant A. baumannii has the potential to reach endemicity in hospitals and warrants more vigorous and innovative efforts to limit its spread.

Original languageEnglish
Pages (from-to)256-260
Number of pages5
JournalJournal of Hospital Infection
Issue number3
StatePublished - Jul 2005


  • Acinetobacter baumannii
  • Bacteraemia
  • Drug resistance
  • Epidemiology
  • Nosocomial


Dive into the research topics of 'Acinetobacter baumannii: Emergence and spread in Israeli hospitals 1997-2002'. Together they form a unique fingerprint.

Cite this